Vimarsana
Biggest News Aggregation in the World

Page 47 - Mc Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mc Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mc Services Today - Breaking & Trending Today

EQS-News: TVM Capital Life Science to participate in LSI USA '23 Emerging Medtech Summit 2023 - Vimarsana News

EQS-News: TVM Capital Life Science to participate in LSI USA '23 Emerging Medtech Summit 2023

EQS-News: TVM Life Science Management GmbH / Key word(s): Conference TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023 17.03.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM Capital Life Science to participate in L...

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Result of General Meeting and Total Voting Rights - Vimarsana News

Investegate |Destiny Pharma PLC Announcements | Destiny Pharma PLC: Result of General Meeting and Total Voting Rights

Investegate announcements from Destiny Pharma PLC, Result of General Meeting and Total Voting Rights

Abivax Adjusts its 2023 Financial Communication Calendar - Vimarsana News

Abivax Adjusts its 2023 Financial Communication Calendar

PARIS, FRANCE / ACCESSWIRE / March 16, 2023 / Abivax SA (Euronext Paris:FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune

Investegate |ONWARD Medical Announcements | ONWARD Medical: ONWARD to Publish Full Year 2022 Financial Results and Host Webcast on March 28, 2023 - Vimarsana News

Investegate |ONWARD Medical Announcements | ONWARD Medical: ONWARD to Publish Full Year 2022 Financial Results and Host Webcast on March 28, 2023

Investegate announcements from ONWARD Medical, ONWARD to Publish Full Year 2022 Financial Results and Host Webcast on March 28, 2023

Newron Pharmaceuticals S.p.A.: Newron Announces 2022 Financial Results and Provides Outlook For 2023 - Vimarsana News

Newron Pharmaceuticals S.p.A.: Newron Announces 2022 Financial Results and Provides Outlook For 2023

Ad hoc announcement pursuant to Art. 53 LR Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients